Woodline Partners LP - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 162 filers reported holding HERON THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 2.49 and the average weighting 0.7%.

Quarter-by-quarter ownership
Woodline Partners LP ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$859,510
-39.6%
569,2120.0%0.01%
-36.8%
Q4 2022$1,423,030
-57.7%
569,212
-28.7%
0.02%
-59.6%
Q3 2022$3,367,000
+47.5%
797,906
-2.5%
0.05%
+34.3%
Q2 2022$2,283,000
-29.9%
818,162
+43.8%
0.04%
-34.0%
Q1 2022$3,256,000
-36.1%
569,155
+2.0%
0.05%
-27.4%
Q4 2021$5,093,000557,7990.07%
Other shareholders
HERON THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
TANG KEVIN 37,999$706,00024.13%
TANG CAPITAL MANAGEMENT LLC 5,744,096$106,783,00014.43%
BRIDGER MANAGEMENT, LLC 2,846,555$52,917,0004.15%
First Light Asset Management, LLC 1,098,723$20,425,0002.84%
Broadfin Capital, LLC 657,998$12,232,0002.66%
HIGHLAND CAPITAL MANAGEMENT LP 1,606,942$29,873,0001.75%
EMORY UNIVERSITY 129,020$2,398,0001.69%
Mesirow Financial Investment Management, Inc. 24,112$430,0001.57%
Congress Park Capital LLC 109,665$1,945,0001.54%
KINGDON CAPITAL MANAGEMENT, L.L.C. 830,821$15,445,0001.52%
View complete list of HERON THERAPEUTICS INC shareholders